Anti-Aging Research: Boswellia Extract Superior To Mesalazine for Crohn's Disease

The purpose of this clinical trial was to compare efficacy and safety of the Boswellia serrata extract with mesalazine for the treatment of active Crohn's disease.

The study confirms that therapy with Boswellia serrata is not inferior to mesalazine. This can be interpreted as evidence for the efficacy of Boswella according to the state of art in the treatment of active Crohn's disease with Boswellia serrata extract, since the efficacy of mesalazine for this indication has been approved by the health authorities. Considering both safety and efficacy of Boswellia serrata extract H15 it appears to be superior over mesalazine in terms of a benefit-risk-evaluation.

View details of this Boswellia mesalazine crohn's disease study abstract.